Last reviewed: June 8, 2026
Last updated: June 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 therapy has transformed how millions approach weight loss by targeting the biological systems that regulate hunger and blood sugar. These medications—including semaglutide injection—activate receptors in your brain and pancreas that control appetite signals and metabolic rate. Clinical trials show participants using GLP-1 medications achieve sustained weight reduction alongside improvements in cardiovascular markers and blood pressure.
How Does GLP-1 Therapy Work for Weight Loss?
GLP-1 (glucagon-like peptide-1) is a hormone your gut naturally produces when you eat, signaling fullness to your brain and slowing stomach emptying. GLP-1 receptor agonists mimic this hormone, amplifying satiety signals so you feel satisfied with smaller portions and experience fewer cravings throughout the day. This dual action on appetite suppression and metabolic regulation creates conditions where sustainable weight loss becomes achievable without relying solely on willpower or restrictive dieting.
The medication also improves insulin sensitivity, helping your body manage blood sugar more effectively and reducing the energy crashes that typically trigger overeating. Research shows that after 16 weeks of GLP-1 therapy, participants report spontaneous reductions in food intake of 500-700 calories daily—a deficit achieved through biological change rather than conscious restriction. This mechanism makes GLP-1 therapy particularly valuable for individuals struggling with constant hunger, food-focused thoughts, or yo-yo dieting patterns.
Clinical Evidence: What the Research Shows About GLP-1 Results
The STEP clinical trials demonstrated that semaglutide injection produced average weight loss of 15-18% over 68 weeks in people with obesity, with some participants achieving losses exceeding 20%. These results represent a significant advancement compared to lifestyle modification alone, which typically yields 3-5% weight loss. Importantly, weight loss with GLP-1 therapy extends beyond aesthetics: participants showed meaningful reductions in blood pressure, triglycerides, and inflammation markers associated with cardiovascular disease.
Real-world data confirms these benefits translate outside clinical settings, with patients maintaining weight loss for years when continuing medication and building sustainable eating habits. Studies tracking long-term outcomes reveal that discontinuing GLP-1 therapy without lifestyle reinforcement typically results in gradual weight regain, underscoring that these medications work best as part of a comprehensive approach including nutrition, movement, and stress management. The cardiovascular benefits—including reduced heart attack and stroke risk in people with type 2 diabetes—extend the value proposition beyond weight loss alone.
Semaglutide Injection vs. Oral Options: Which Delivery Method Suits You?
Semaglutide comes in two primary forms through PlexusDx: injection (starting at $149/mo from licensed 503A compounding pharmacies) and oral tablets. The injectable format delivers medication directly into subcutaneous tissue, providing consistent blood levels and typically faster results for weight loss—most patients notice appetite suppression within 3-5 days of their first dose. Injections require a small needle (similar to insulin delivery) once weekly, and many patients find this schedule simpler than managing daily pills.
Oral semaglutide offers convenience for needle-averse patients and requires only daily dosing, though it demands strict adherence to absorption guidelines (taking on an empty stomach with specific timing). Injectable formulations from PlexusDx are compounded at licensed 503A pharmacies, ensuring pharmaceutical-grade quality without the premium cost of branded versions. Your PlexusDx provider helps match the delivery method to your lifestyle, preferences, and how quickly you need results—your dose may need to go up, but your price won't change across commitment tiers.
Understanding Side Effects and Safety of GLP-1 Medications
The most common side effects during GLP-1 therapy include mild nausea, constipation, and decreased appetite—reactions that typically diminish within 2-4 weeks as your body adjusts. These effects are actually the mechanism at work: nausea signals appetite suppression, and constipation often reflects reduced food intake. Serious adverse events are rare in clinical populations, and most patients tolerate GLP-1 therapy well, with discontinuation rates due to side effects below 5% in major trials.
PlexusDx providers screen for contraindications before starting therapy, including personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2. Pregnant individuals and those planning pregnancy should not use GLP-1 medications, though no evidence suggests permanent fertility effects after discontinuation. Regular check-ins with your PlexusDx provider help catch any emerging concerns early and adjust dosing to minimize discomfort while maintaining weight loss momentum.
Personalized GLP-1 Therapy: The Role of Genetic Testing
PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month), a peptide-pathway genetic assessment that identifies variants affecting how your body responds to GLP-1 medications. This test examines 150+ genetic insights across 49 peptides and 14 metabolic pathways, including key variants like GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609 that influence appetite regulation and weight distribution. Understanding your genetic predispositions allows your provider to select the optimal medication type and dosing strategy faster, reducing the trial-and-error period.
Some patients carry genetic variants that predict stronger responses to GLP-1 therapy, while others benefit more from combination approaches like GLP-Squared (semaglutide plus tirzepatide dual compound). The Precision Peptide test also illuminates why certain people struggle with specific hunger patterns or metabolic challenges—information that informs nutrition counseling and lifestyle recommendations. This personalized layer transforms GLP-1 therapy from a one-size-fits-all medication into precision medicine tailored to your unique biology.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How quickly will I see weight loss results with semaglutide injection?
Most patients notice reduced appetite within 3-5 days of starting semaglutide injection, with visible weight loss appearing by 2-4 weeks as calorie intake naturally decreases. Average weight loss in clinical trials reached 1-2 pounds per week over the first 8-12 weeks, then stabilized at a slower but steady pace. PlexusDx providers monitor your progress at regular check-ins and may adjust your dose if needed to optimize results.
Is GLP-1 therapy safe for people without diabetes?
Yes, GLP-1 medications are FDA-approved for chronic weight management in people with obesity or overweight with weight-related conditions, regardless of diabetes status. Clinical trials like STEP enrolled primarily non-diabetic populations and confirmed safety and efficacy. PlexusDx screens all patients for contraindications before starting, and compounded medications from licensed 503A pharmacies meet pharmaceutical standards.
What is the monthly cost of semaglutide injection at PlexusDx?
PlexusDx compounded semaglutide injection starts at $149/mo across three commitment tiers, with your dose able to increase while your monthly price remains flat—eliminating the typical escalating costs of branded medications. The service includes no insurance requirement, no membership fees, and eligibility for HSA/FSA accounts. All medications come from licensed 503A compounding pharmacies, ensuring quality at accessible pricing.
What happens to my weight if I stop taking GLP-1 medication?
Studies show that stopping GLP-1 therapy typically results in gradual weight regain over 6-12 months, though most patients maintain at least 50% of their initial weight loss if they continue the lifestyle changes learned during treatment. GLP-1 therapy is most effective as a long-term tool paired with sustainable eating and activity habits rather than a temporary intervention. PlexusDx providers help you develop these behavioral foundations alongside medication to preserve results.
How does the Precision Peptide Genetic Test improve my GLP-1 treatment?
PlexusDx's Precision Peptide Genetic Test identifies variants in appetite-regulation genes (GLP1R, GIPR, FTO, MC4R) and 150+ other genetic insights that predict how strongly you'll respond to GLP-1 therapy and whether combination approaches might serve you better. This test ($99 add-on after first month) eliminates guesswork, helping your provider choose semaglutide, tirzepatide, or dual-compound GLP-Squared based on your biology. Understanding your genetic predispositions accelerates results and personalizes your entire treatment strategy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Semaglutide Dosage for Weight Loss: Complete Titration Guide
Where to Get GLP-1: A Guide to Finding Effective Weight Loss Solutions